Amitriptyline hydrochloride; perphenazine - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for amitriptyline hydrochloride; perphenazine and what is the scope of freedom to operate?

Amitriptyline hydrochloride; perphenazine is the generic ingredient in ten branded drugs marketed by Schering, Chartwell Rx, Fosun Pharma, Ivax Sub Teva Pharms, Mylan, Par Pharm, Sun Pharm Industries, Watson Labs, and New River, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for amitriptyline hydrochloride; perphenazine

US Patents:	0
Tradenames:	10
Applicants:	9
NDAs:	37
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	6
Clinical Trials:	1
Patent Applications:	58
DailyMed Link:	amitriptyline hydrochloride; perphenazine at DailyMed

Recent Clinical Trials for amitriptyline hydrochloride; perphenazine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Institute of Experimental and Clinical Therapeutics	Phase 2
Hospital Civil de Guadalajara	Phase 2
University of Guadalajara	Phase 2

See all amitriptyline hydrochloride; perphenazine clinical trials

Pharmacology for amitriptyline hydrochloride; perphenazine

Drug Class	Phenothiazine Tricyclic Antidepressant

Anatomical Therapeutic Chemical (ATC) Classes for amitriptyline hydrochloride; perphenazine

N05AB	Phenothiazines with piperazine structure
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

N06AA	Non-selective monoamine reuptake inhibitors
N06A	ANTIDEPRESSANTS
N06	PSYCHOANALEPTICS
N	Nervous system

US Patents and Regulatory Information for amitriptyline hydrochloride; perphenazine

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fosun Pharma	PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride; perphenazine	TABLET;ORAL	071862-001	Dec 21, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride; perphenazine	TABLET;ORAL	072135-001	Feb 15, 1989		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Watson Labs	PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride; perphenazine	TABLET;ORAL	071558-001	Mar 2, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fosun Pharma	PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE	amitriptyline hydrochloride; perphenazine	TABLET;ORAL	071062-001	Nov 27, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for amitriptyline hydrochloride; perphenazine

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Schering	ETRAFON 2-10	amitriptyline hydrochloride; perphenazine	TABLET;ORAL	014713-007	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Schering	ETRAFON-FORTE	amitriptyline hydrochloride; perphenazine	TABLET;ORAL	014713-006	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
New River	TRIAVIL 2-25	amitriptyline hydrochloride; perphenazine	TABLET;ORAL	014715-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
New River	TRIAVIL 4-50	amitriptyline hydrochloride; perphenazine	TABLET;ORAL	014715-006	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.